Revel Pharmaceuticals

About:

Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.

Website: https://www.revelpharmaceuticals.com/

Top Investors: Starbloom Capital, KIZOO Technology Capital, Tubus

Description:

Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage.

Total Funding Amount:

$8.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2019-01-01

Founders:

AARON CRAVENS, Nicholas DeLateur

Number of Employees:

1-10

Last Funding Date:

2022-03-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai